Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Halozyme therapeutics, inc. symbols : GSK save search
Investor Alert - The M&A Class Action Firm is Investigating the Merger - ATRS, SRRA, SAIL, MSP, CDK, VWTR
Published: 2022-04-18 (Crawled : 22:00) - prnewswire.com
SAIL | $65.24 -0.03%
|
Technology Services
|
| O: -0.3%
H: 0.14%
C: 0.09%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.52%
H: 0.63%
C: -0.15%
MSP 4 | $35.18 0.51%
|
Technology Services
|
| O: 0.0%
H: 0.29%
C: 0.17%
DHI | $142.19 -2.53% 0.06% 3.4M
|
Consumer Durables
|
| O: 0.35%
H: 3.95%
C: 3.52%
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: -0.36%
IESC | News | $115.44 -0.37% -0.37% 120K
|
Industrial Services
|
| O: 0.68%
H: 1.74%
C: 1.09%
HALO M | $38.64 2.2% 2.15% 1.3M
|
Health Technology
|
| O: 0.57%
H: 2.81%
C: 1.26%
CDK | $54.76 -0.15% 0.07%
|
Commercial Services
|
| O: 0.06%
H: 0.02%
C: -0.04%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -0.18%
H: 0.36%
C: 0.0%
Halozyme Reports Second Quarter 2021 Results
Published: 2021-08-09 (Crawled : 20:00) - halozyme.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.02%
H: 0.38%
C: 0.15%
HALO M | $38.64 2.2% 2.15% 1.3M
|
Health Technology
|
| O: 14.02%
H: 0.17%
C: -10.56%
results report
ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of "ultra-long-acting" medicines for HIV
Published: 2021-06-22 (Crawled : 07:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.03%
H: 0.71%
C: 0.51%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.7%
H: 0.05%
C: -1.06%
HALO M | $38.64 2.2% 2.15% 1.3M
|
Health Technology
|
| O: 0.19%
H: 2.15%
C: 1.89%
collaboration drug license technology drug delivery liver hiv
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.